Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Fertility and Sterility

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.fertnstert.2011.07.002PMID 21813121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin in polycystic ovary syndrome

  2010cited by this paper
• Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

  2010cited by this paper
• Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• ACOG Practice Bulletin No. 108: Polycystic ovary syndrome.

  2009cited by this paper
• International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

  2009cited by this paper
• HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

  2007cited by this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.

  2007cited by this paper
• HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review

  2007cited by this paper
• Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

  2007cited by this paper
• Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling

  2006cited by this paper
• Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

  2006cited by this paper
• The dependence of Cohen's kappa on the prevalence does not matter.

  2005cited by this paper
• American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.

  2005cited by this paper
• Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.

  2005cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.

  2004cited by this paper
• Use and abuse of HOMA modeling.

  2004cited by this paper
• Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations.

  2002cited by this paper
• Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.

  2002cited by this paper
• Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome.

  2002cited by this paper
• Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

  1999cited by this paper
• Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

  1999cited by this paper
• Consensus Development Conference on Insulin Resistance: 5–6 November 1997

  1998cited by this paper
• Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

  1998cited by this paper
• A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.

  1998cited by this paper
• Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

  1989cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Clinical assessment of body hair growth in women.

  1961cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected

  year unknowncited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study*

  year unknowncited by this paper
• CLINICAL MANAGEMENT GUIDELINES FOR OBSTETRICIAN – GYNECOLOGISTS

  year unknowncited by this paper

• Advancement in early diagnosis of polycystic ovary syndrome: biomarker-driven innovative diagnostic sensor

  2025cites this paper
• Measures of Serum Markers HbA1c, HOMA-IR, HOMA-β, QUICKI and G/I Ratio as Predictors of Abnormal Glucose Tolerance Among Thai Women with Polycystic Ovary Syndrome

  2025cites this paper
• Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis.

  2024cites this paper
• Markers of insulin resistance in Polycystic ovary syndrome women: An update

  2022cites this paper
• Increased pro-inflammatory cytokines in ovary and effect of γ-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model.

  2021cites this paper
• From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management

  2020cites this paper
• Resistencia a la insulina en mujeres con síndrome de ovario poliquístico

  2020influential citation
• Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?

  2019cites this paper
• Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients

  2019cites this paper
• Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?

  2018cites this paper
• Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome

  2017cites this paper
• Insulin Resistance and β-cell Function Calculated by Homeostasis Model Assessment in Lean, Overweight, and Obese Women with Polycystic Ovary Syndrome.

  2016cites this paper
• Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome

  2016influential citation
• Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.

  2016cites this paper
• What does a diagnostic label of ‘polycystic ovary syndrome’ really mean in adolescence? a review of current practice recommendations

  2016cites this paper
• A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome.

  2016cites this paper
• Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome

  2016cites this paper
• Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future

  2015cites this paper
• Transcription Factor-7-Like 2 Gene Variants Affect the Metabolic Phenotypes of Polycystic Ovary Syndrome

  2015cites this paper
• Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients

  2015cites this paper
• Complications and challenges associated with polycystic ovary syndrome : current perspectives

  2015cites this paper
• СИНДРОМ ПОЛИКИСТОЗНЫХ ЯИЧНИКОВ * ОФИЦИАЛЬНОЕ ЗАЯВЛЕНИЕ ЕВРОПЕЙСКОГО ОБЩЕСТВА ЭНДОКРИНОЛОГИИ (EUROPEAN SOCIETY OF ENDOCRINOLOGY, ESE)

  2015cites this paper
• Síndrome de ovario poliquístico y complicaciones metabólicas: más allá del exceso de andrógenos

  2015cites this paper
• Third trimester insulin levels are not correlated with fetal macrosomia or delivery complications.

  2014cites this paper
• The Polycystic Ovary Syndrome : an Endocrinological Perspective from 1 the European Society of Endocrinology 2 3 The ESE PCOS Special Interest Group :

  2014cites this paper
• Is Glycated Hemoglobin Related to other Dysmetabolic Variables Implicated in the Increase of Cardiovascular Risk in Polycystic Ovary Syndrome? A Comparative Study

  2014cites this paper
• Diagnosing dysglycemia in adolescents with polycystic ovary syndrome.

  2014influential citation
• Screening for glucose intolerance in polycystic ovary syndrome: hemoglobin A1C, fasting blood glucose or oral glucose tolerance test?

  2014cites this paper
• The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.

  2014cites this paper
• Polycystic Ovary Syndrome

  2013cites this paper
• Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.

  2013cites this paper
• Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention

  2013cites this paper
• Current world literature.

  2012cites this paper
• PCOS and assisted reproduction

  2012cites this paper
• The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome

  2012influential citation
• An 1 h-OGLT is an Appropriate Approach for the Determination of Glucose and Insulin Dynamics in Female Functional Androgenization (Including “Polycystic Ovary Syndrome”)

  2012cites this paper
• Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome.

  2012cites this paper
• [The importance of oral glucose tolerance test in diagnosis of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome].

  2012cites this paper
• Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome

  2012cites this paper
• International Journal of Women's Health Dovepress Complications and Challenges Associated with Polycystic Ovary Syndrome: Current Perspectives

  year unknowncites this paper
• A review on type 2 diabetes mellitus in patients with polycystic ovary syndrome: Study on the risk factor, pathogenesis, lifestyle modification and pharmacological treatment

  year unknowncites this paper